Home   ->   news   ->   Press Releases

Press Releases

2015

News Archives: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

2015/08/26
WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm

2015/08/14
WuXi Pharmatech Enters Into Definitive Merger Agreement

2015/08/10
WuXi PharmaTech and TruTag Technologies Complete Successful Testing of Edible On-Dose Authentication Solution for Pharmaceuticals

2015/07/10
WuXi PharmaTech's China-Based Small-Molecule Manufacturing Subsidiary, STA, Enters into Private Placement Agreement

2015/06/04
WuXi AppTec Partners with Fudan University and the Collaborative Innovation Center of Genetics and Development

2015/06/03
WuXi NextCODE Wins Genomics England Clinical Interpretation Tender in both Rare Disease and Cancer

2015/05/21
WuXi Launches e-Commerce Platform for Chemistry Products

2015/05/21
Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx

2015/04/30
WuXi PharmaTech Announces Receipt of Proposal

2015/04/30
WuXi Biologics Begins Construction of the World's Largest Mammalian Cell Culture Manufacturing Facility Using Disposable Bioreactors

2015/04/23
WuXi PharmaTech Schedules First-Quarter 2015 Earnings Release

2015/04/22
Big Data and Genomics Meet the Cloud: the First Unified Global Platform for Precision Medicine

2015/04/08
Nobel Prize Laureate Professor Barry Sharpless Visits WuXi AppTec Headquarters in Shanghai

2015/04/02
WuXi PharmaTech Lists Shares of Small-Molecule Manufacturing Subsidiary STA on New Third Board in China

2015/03/27
Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA

2015/03/25
Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide

2015/03/12
WuXi PharmaTech To Build New Cell Therapy Manufacturing Facility for CAR T Cells and Other Cancer Immunotherapies

2015/03/05
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results

2015/02/27
WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA

2015/02/17
WuXi PharmaTech Enters into Syndicated Loan Agreement

2015/02/13
WuXi PharmaTech Schedules Fourth-Quarter 2014 Earnings Release

2015/02/06
WuXiPRA Appoints Two Key Executives

2015/01/30
WuXi PharmaTech's Small-Molecule Manufacturing Subsidiary STA Wins CMO Leadership Award

2015/01/09
WuXi PharmaTech Acquires NextCODE Health to Create Global Leader in Genomic Medicine

2015/01/09
WuXi PharmaTech Provides Update of 2014 Financial Guidance, to Present at J.P. Morgan Healthcare Conference

2015/01/05
WuXi Launches Mobile App to Enable Chemistry-on-the-Go